Arena Pharmaceuticals, Inc. (ARNA)

[mick]

part two/ Cannabinoid Receptor Modulators
https://finance.search.yahoo.com/search/;_ylc=X3oDMTJtN2poNzRjBGtleXcDQ2FubmFiaW5vaWQgUmVjZXB0b3IgTW9kdWxhdG9ycwRtaWQDbWVkaWFxdW90ZXNzZWFyY2gEc2VjA3VoYjIEc2xrA2ZpbmFuY2Vfc2VhcmNo?p=Cannabinoid%20Receptor%20Modulators&type=2button&fr=uh3_finance_vert_gs

Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office
PR Newswire via Yahoo! Finance 2 hours ago
SAN DIEGO, July 15, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) announced today that it was granted U.S. Patent No. 8,778,950, entitled "Cannabinoid Receptor Modulators," by the United States Patent and Trademark Office for APD371, an agonist of the cannabinoid receptor 2 (CB2). Arena is exploring several potential indications for APD371, including chronic pain, and is currently ...